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The NADH:ubiquinone oxidoreductase (EC 1.6.5.3., complex I)
couples the electron transfer from NADH to ubiquinone with a proton
translocation across the membrane. It consists of two arms, the
peripheral and the membrane arm. The structure of the bacterial
complex I showed that the NADH binding site is made up by a novel
type Rossman-fold providing binding sites for the FMN as well as for
NADH. We solved the structure of the NADH binding site of the
Aquifex aeolicus enzyme with bound substrates at 2 Å resolution.
From the structure it is evident, that the Glu 183 (numbering
according to E. coli complex I) provides one of the most prominent
interactions with NADH by building a hydrogen bond to the hydroxyl
group of C2’-ribose. The affinity of the E. coli complex I to NADH is 50
times higher than that to NADPH. The reason could be a sterical clash
between the C2’-PO32− of NADPH and the Glu183-side chain. This
prediction is examined by testing the activity of protein variants with
mutations at this position. The effect of the mutations on the NAD(P)
H/ferricyanide, NAD(P)H/HAR and NAD(P)H:decylubiquinone oxi-
doreductase activity will be examined.
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In the course of wide structural modifications of natural aceto-
genins, we synthesized “Δlac-acetogenins” by deleting a γ-lactone
ring that is a structural feature common to a large number of natural
acetogenins. Characterization of the inhibition mechanism of Δlac-
acetogenins revealed that they are a new type of complex I inhibitors;
for instance, i) the level of superoxide production induced by Δlac-
acetogenins is remarkably low and ii) the inhibitory potency for the
reverse electron transfer is significantly weaker than that for the
forward event [1, 2]. Considering the unusual inhibitory effects of
Δlac-acetogenins, further exploration of their inhibition manner
including identification of the binding site would provide valuable
insights into the terminal electron transfer step of complex I. In order
to clarify the binding site of Δlac-acetogenins, we here synthesized a
photoreactive Δlac-acetogenin ([125I]diazirinylated Δlac-acetogenin,
[125I]DAA), which has a small photolabile diazirine group attached to
a pharmacophore (bis-THF ring moiety), and carried out photoaffinity
labeling with bovine heart submitochondrial particles (SMP).
Biochemical characterization revealed that DAA retains very potent
inhibitory activity at nM level, whereas its inhibition mechanism
differs slightly from that of the original Δlac-acetogenins. Analysis of
the SMP photocross-linked by [125I]DAA revealed that [125I]DAA binds
to the ND1 subunit in the membrane domain with a high specificity.
The Lys-C and Asp-N digest of the cross-linked ND1 and careful
analysis of the peptide fragments suggested that [125I]DAA binds to
two different sites in the ND1 subunit; one is located between Tyr127
and Phe198 (covering 4th and 5th transmembrane helices) and the
other is located between Asp199 and Lys262 (covering 6th and 7th
transmembrane helices). Consideration that a photolabile diazirine
group is attached at hydrophilic moiety of amphiphilic [125I]DAA, the
cross-linked residues may be located in the loop region connecting
the 5th and 6th transmembrane helices. In the presence of an ex-
cess amount of Δlac-acetogenin, the cross-linking solely of the re-
gion Asp199–Lys262 was completely suppressed. This result strongly
suggests that Δlac-acetogenin binds this region with a high
specificity.
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Ithasbeenknownthatvariousenergy transducingmembrane systems
utilize protein-associated quinone molecules. Based upon EPR spin-
coupling studies, T. Ohnishi and her collaborators reported that bovine
heart NADH–ubiquinone oxidoreductase (complex I) contains two
different types of semiquinone. They called them fast relaxing semiqui-
none (SQNf) and slow relaxing semiquinone (SQNs) [1–4], and assigned
each of themdifferent roles. The former is for gated-proton transport, and
the latter, for the converter between one-electron and two-electron
transport. In recent years, complex I has been isolated and purified in
many laboratories. A problem in the purification of complex I seems to be
that quinone is easily lost during the purification. Recently, Yoshikawa's
group reported that their highly purified, active bovine heart complex I
preparations maintain one protein-associated ubiquinone per complex I
molecule [5]. Using these preparations, we detected EPR signals of both
semiflavin (SF) and semiquinone (SQ) radicals (S. T. Ohnishi et al. BBA. in
press). We now report that we detected the signal from endogeneously-
bound semiquinone, and succeeded in separating signals from two types
of semiquinone. Possible implications are twofold. The first role: three
types of quinone-inhibitors, Type-A (piericidin A), Type-B (rotenone) and
Type-C (capsaicin and tridecylstigmatellin) are known [6–7]. This
categorization of inhibitors may be explained by the binding specificity
of these inhibitors to the QNf and QNs sites. For example, piericidin A binds
to both QNf and QNs, rotenone binds preferentially to QNf and TDS binds to
QNs. The second role is their involvement in electron–proton coupling. T.
Ohnishi now hypothesizes that QNs may also play an important role in
indirect electron–proton coupling.
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